Changes in QICA Score and Clinical Quality Measures Between Baseline and Follow-up
| Measure | Baseline, Mean (SD) | Follow-Up, Mean (SD) | Change, Mean (95% CI) | P Valuea |
|---|---|---|---|---|
| QICA scoreb | ||||
| Total score | 6.45 (1.39) | 7.88 (1.4) | 1.44 (1.20-1.68) | <.001 |
| HLC subscore | <.001 | |||
| 1. Embed clinical evidence | 6.95 (2.29) | 8.32 (1.74) | 1.37 (1.01-1.73) | <.001 |
| 2. Utilize data to improve Performance | 4.98 (2.43) | 6.97 (2.40) | 1.98 (1.58-2.39) | <.001 |
| 3. Establish regular QI processes | 5.14 (2.20) | 7.39 (2.16) | 2.25 (1.85-2.65) | <.001 |
| 4. Identify at-risk patients | 5.46 (1.86) | 7.06 (1.85) | 1.60 (1.27-1.93) | <.001 |
| 5. Define roles and responsibilities | 6.96 (1.80) | 8.15 (1.80) | 1.20 (0.90-1-.51) | <.001 |
| 6. Improve patient self-management | 7.44 (1.82) | 8.51 (1.78) | 1.08 (0.78-1.39) | <.001 |
| 7. Link patients to outside resources | 8.20 (1.64) | 8.99 (1.40) | 0.79 (0.52-1.07) | <.001 |
| Clinical Quality Measurec | ||||
| Aspirin use, % | 66.81 (16.61) | 70.79 (13.20) | 3.98 (1.17-6.79) | .006 |
| Blood pressure control, % | 61.48 (12.00) | 64.84 (11.48) | 3.36 (1.44-5.27) | .001 |
| Smoking screening/cessation counseling, % | 73.78 (22.88) | 81.27 (21.26) | 7.49 (4.21-10.77) | <.001 |
HLC = high-leverage change; QI = quality improvement; QICA = Quality Improvement Capacity Assessment.
↵aFrom a t test that tested for differences of the mean change from zero.
↵bLimited to clinics that completed both QICA surveys (N = 165). Possible range of total score and of each HLC subscore is 1 to 12 points; higher scores denote greater QI capacity.
↵cPercent of the eligible patient population achieving the measure. Limited to clinics that completed both QICA surveys and reported clinical quality measures in both 2015 and 2017 (N = 130 for aspirin use, N = 161 for blood pressure control, and N = 130 for smoking screening/cessation counseling).